Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Stephan

Showing results (151-160 of 222) with videos related to

Pageof 23
Sort By:
International Journal of Cancer|May 18, 2010
KLK15 is a prognostic marker for progression-free survival in patients with radical prostatectomyAnja Rabien, Florian R Fritzsche, Monika Jung, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 20, 2009
Reduced serum selenoprotein P concentrations in German prostate cancer patientsHellmuth-Alexander Meyer, Birgit Hollenbach, Carsten Stephan, et al.
BMC Urology|November 22, 2014
Staging lymphadenectomy in patients with localized high risk prostate cancer: comparison of the laparoendoscopic single site (LESS) technique with conventional multiport laparoscopyFrank Friedersdorff, Seven Johannes Aghdassi, Ahmed Magheli, et al.
Radiology|June 5, 2019
Image-guided Irreversible Electroporation of Localized Prostate Cancer: Functional and Oncologic OutcomesFederico Collettini, Judith Enders, Carsten Stephan, et al.
Asian Journal of Andrology|August 19, 2014
Risk prediction models for biochemical recurrence after radical prostatectomy using prostate-specific antigen and Gleason scoreXin-Hai Hu, Henning Cammann, Hellmuth-A Meyer, et al.
BJU International|November 13, 2013
Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarraysAnnette Zimpfer, Matthias Maruschke, Stefan Rehn, et al.
British Journal of Cancer|February 21, 2019
Apelin and apelin receptor expression in renal cell carcinomaYuri Tolkach, Jörg Ellinger, Anika Kremer, et al.
Clinical Chemistry|May 26, 2011
Between-method differences in prostate-specific antigen assays affect prostate cancer risk prediction by nomogramsCarsten Stephan, Kerstin Siemssen, Henning Cammann, et al.
International Journal of Oncology|January 21, 2022
Overexpression of Parkin in clear cell renal cell carcinoma decreases tumor aggressiveness by regulating CKS2 levelsLaura Kristin Esser, Vittorio Branchi, Farhad Shakeri, et al.
International Journal of Oncology|January 19, 2008
Expression of the ELAV-like protein HuR in human prostate carcinoma is an indicator of disease relapse and linked to COX-2 expressionSilvia Niesporek, Glen Kristiansen, Andrea Thoma, et al.
Pageof 23

Showing results (151-160 of 222) with videos related to

Sort By:
Pageof 23
International Journal of Cancer|May 18, 2010
KLK15 is a prognostic marker for progression-free survival in patients with radical prostatectomyAnja Rabien, Florian R Fritzsche, Monika Jung, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 20, 2009
Reduced serum selenoprotein P concentrations in German prostate cancer patientsHellmuth-Alexander Meyer, Birgit Hollenbach, Carsten Stephan, et al.
BMC Urology|November 22, 2014
Staging lymphadenectomy in patients with localized high risk prostate cancer: comparison of the laparoendoscopic single site (LESS) technique with conventional multiport laparoscopyFrank Friedersdorff, Seven Johannes Aghdassi, Ahmed Magheli, et al.
Radiology|June 5, 2019
Image-guided Irreversible Electroporation of Localized Prostate Cancer: Functional and Oncologic OutcomesFederico Collettini, Judith Enders, Carsten Stephan, et al.
Asian Journal of Andrology|August 19, 2014
Risk prediction models for biochemical recurrence after radical prostatectomy using prostate-specific antigen and Gleason scoreXin-Hai Hu, Henning Cammann, Hellmuth-A Meyer, et al.
BJU International|November 13, 2013
Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarraysAnnette Zimpfer, Matthias Maruschke, Stefan Rehn, et al.
British Journal of Cancer|February 21, 2019
Apelin and apelin receptor expression in renal cell carcinomaYuri Tolkach, Jörg Ellinger, Anika Kremer, et al.
Clinical Chemistry|May 26, 2011
Between-method differences in prostate-specific antigen assays affect prostate cancer risk prediction by nomogramsCarsten Stephan, Kerstin Siemssen, Henning Cammann, et al.
International Journal of Oncology|January 21, 2022
Overexpression of Parkin in clear cell renal cell carcinoma decreases tumor aggressiveness by regulating CKS2 levelsLaura Kristin Esser, Vittorio Branchi, Farhad Shakeri, et al.
International Journal of Oncology|January 19, 2008
Expression of the ELAV-like protein HuR in human prostate carcinoma is an indicator of disease relapse and linked to COX-2 expressionSilvia Niesporek, Glen Kristiansen, Andrea Thoma, et al.
Pageof 23